What is the current stock price of Immune Therapeutics, Inc. (IMUN)?

As of the latest market data, Immune Therapeutics, Inc. (IMUN) is trading at $0.09. The stock has seen a loss of -7.00% today.

Does Immune Therapeutics, Inc. (IMUN) pay a dividend?

Based on current data, Immune Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Immune Therapeutics, Inc.?

The current market capitalization of Immune Therapeutics, Inc. (IMUN) is approximately unavailable.

IMUN

Immune Therapeutics, Inc.·Healthcare

0.09

7.000%(−0.01)

Close Price

Last Updated: — ET

52W L: $0.0752W H: $1.30

IMUN NEWS

defenseworld.net

Apr 4

Critical Analysis: Immune Therapeutics (OTCMKTS:IMUN) & MBX Biosciences (NASDAQ:MBX)

Immune Therapeutics (OTCMKTS:IMUN - Get Free Report) and MBX Biosciences (NASDAQ: MBX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Earnings and Valuation This table compares Immune

Company Profile

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.

Sector

Healthcare

Industry

Biotechnology

IPO Date

2010-08-20

Beta

0.26

Websitewww.immunetherapeutics.com↗